Logo image of TECH

BIO-TECHNE CORP (TECH) Stock Fundamental Analysis

USA - NASDAQ:TECH - US09073M1045 - Common Stock

57.41 USD
-0.77 (-1.32%)
Last: 11/7/2025, 8:20:54 PM
57.41 USD
0 (0%)
After Hours: 11/7/2025, 8:20:54 PM
Fundamental Rating

6

Overall TECH gets a fundamental rating of 6 out of 10. We evaluated TECH against 58 industry peers in the Life Sciences Tools & Services industry. TECH gets an excellent profitability rating and is at the same time showing great financial health properties. TECH is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

TECH had positive earnings in the past year.
In the past year TECH had a positive cash flow from operations.
In the past 5 years TECH has always been profitable.
In the past 5 years TECH always reported a positive cash flow from operatings.
TECH Yearly Net Income VS EBIT VS OCF VS FCFTECH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.82%, TECH is in the better half of the industry, outperforming 74.14% of the companies in the same industry.
TECH's Return On Equity of 3.77% is fine compared to the rest of the industry. TECH outperforms 70.69% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.18%, TECH belongs to the top of the industry, outperforming 84.48% of the companies in the same industry.
TECH had an Average Return On Invested Capital over the past 3 years of 9.00%. This is below the industry average of 13.50%.
The 3 year average ROIC (9.00%) for TECH is below the current ROIC(9.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.82%
ROE 3.77%
ROIC 9.18%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
TECH Yearly ROA, ROE, ROICTECH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

TECH's Profit Margin of 5.92% is fine compared to the rest of the industry. TECH outperforms 74.14% of its industry peers.
In the last couple of years the Profit Margin of TECH has declined.
TECH's Operating Margin of 21.73% is amongst the best of the industry. TECH outperforms 91.38% of its industry peers.
TECH's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 66.49%, TECH belongs to the best of the industry, outperforming 91.38% of the companies in the same industry.
TECH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 21.73%
PM (TTM) 5.92%
GM 66.49%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
TECH Yearly Profit, Operating, Gross MarginsTECH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

7

2. Health

2.1 Basic Checks

TECH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, TECH has less shares outstanding
The number of shares outstanding for TECH has been increased compared to 5 years ago.
The debt/assets ratio for TECH is higher compared to a year ago.
TECH Yearly Shares OutstandingTECH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
TECH Yearly Total Debt VS Total AssetsTECH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 10.00 indicates that TECH is not in any danger for bankruptcy at the moment.
TECH's Altman-Z score of 10.00 is amongst the best of the industry. TECH outperforms 93.10% of its industry peers.
The Debt to FCF ratio of TECH is 1.35, which is an excellent value as it means it would take TECH, only 1.35 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.35, TECH belongs to the best of the industry, outperforming 87.93% of the companies in the same industry.
TECH has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
TECH's Debt to Equity ratio of 0.18 is in line compared to the rest of the industry. TECH outperforms 55.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.35
Altman-Z 10
ROIC/WACC0.88
WACC10.48%
TECH Yearly LT Debt VS Equity VS FCFTECH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 3.46 indicates that TECH has no problem at all paying its short term obligations.
TECH has a Current ratio of 3.46. This is in the better half of the industry: TECH outperforms 60.34% of its industry peers.
A Quick Ratio of 2.38 indicates that TECH has no problem at all paying its short term obligations.
The Quick ratio of TECH (2.38) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.46
Quick Ratio 2.38
TECH Yearly Current Assets VS Current LiabilitesTECH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.82% over the past year.
The Earnings Per Share has been growing by 11.25% on average over the past years. This is quite good.
TECH shows a small growth in Revenue. In the last year, the Revenue has grown by 5.23%.
Measured over the past years, TECH shows a quite strong growth in Revenue. The Revenue has been growing by 10.55% on average per year.
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
Revenue 1Y (TTM)5.23%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%

3.2 Future

Based on estimates for the next years, TECH will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.61% on average per year.
Based on estimates for the next years, TECH will show a small growth in Revenue. The Revenue will grow by 7.10% on average per year.
EPS Next Y5.89%
EPS Next 2Y8.87%
EPS Next 3Y9.27%
EPS Next 5Y8.61%
Revenue Next Year1.85%
Revenue Next 2Y4.68%
Revenue Next 3Y5.9%
Revenue Next 5Y7.1%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TECH Yearly Revenue VS EstimatesTECH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
TECH Yearly EPS VS EstimatesTECH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.75 indicates a quite expensive valuation of TECH.
Based on the Price/Earnings ratio, TECH is valued a bit cheaper than 65.52% of the companies in the same industry.
TECH is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.83, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 25.10, the valuation of TECH can be described as expensive.
Based on the Price/Forward Earnings ratio, TECH is valued a bit cheaper than the industry average as 74.14% of the companies are valued more expensively.
TECH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 32.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.75
Fwd PE 25.1
TECH Price Earnings VS Forward Price EarningsTECH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

68.97% of the companies in the same industry are more expensive than TECH, based on the Enterprise Value to EBITDA ratio.
TECH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TECH is cheaper than 70.69% of the companies in the same industry.
Industry RankSector Rank
P/FCF 34.84
EV/EBITDA 24.33
TECH Per share dataTECH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of TECH may justify a higher PE ratio.
PEG (NY)5.05
PEG (5Y)2.64
EPS Next 2Y8.87%
EPS Next 3Y9.27%

4

5. Dividend

5.1 Amount

TECH has a yearly dividend return of 0.55%, which is pretty low.
TECH's Dividend Yield is rather good when compared to the industry average which is at 0.50. TECH pays more dividend than 93.10% of the companies in the same industry.
With a Dividend Yield of 0.55, TECH pays less dividend than the S&P500 average, which is at 2.37.
Industry RankSector Rank
Dividend Yield 0.55%

5.2 History

The dividend of TECH has a limited annual growth rate of 0.11%.
TECH has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of TECH decreased recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
TECH Yearly Dividends per shareTECH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

69.74% of the earnings are spent on dividend by TECH. This is not a sustainable payout ratio.
TECH's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP69.74%
EPS Next 2Y8.87%
EPS Next 3Y9.27%
TECH Yearly Income VS Free CF VS DividendTECH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
TECH Dividend Payout.TECH Dividend Payout, showing the Payout Ratio.TECH Dividend Payout.PayoutRetained Earnings

BIO-TECHNE CORP

NASDAQ:TECH (11/7/2025, 8:20:54 PM)

After market: 57.41 0 (0%)

57.41

-0.77 (-1.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-03 2026-02-03/bmo
Inst Owners103.36%
Inst Owner Change-0.78%
Ins Owners0.26%
Ins Owner Change2.51%
Market Cap8.94B
Revenue(TTM)1.22B
Net Income(TTM)72.26M
Analysts81.74
Price Target67.89 (18.25%)
Short Float %4.47%
Short Ratio3
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP69.74%
Div Incr Years0
Div Non Decr Years1
Ex-Date11-17 2025-11-17 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.75%
Min EPS beat(2)4.14%
Max EPS beat(2)7.36%
EPS beat(4)4
Avg EPS beat(4)6.45%
Min EPS beat(4)4.14%
Max EPS beat(4)7.75%
EPS beat(8)5
Avg EPS beat(8)1.79%
EPS beat(12)5
Avg EPS beat(12)-3.41%
EPS beat(16)8
Avg EPS beat(16)-2.01%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)-1.54%
Revenue beat(4)2
Avg Revenue beat(4)-0.34%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.28%
Revenue beat(8)3
Avg Revenue beat(8)-1.36%
Revenue beat(12)3
Avg Revenue beat(12)-2.62%
Revenue beat(16)5
Avg Revenue beat(16)-2%
PT rev (1m)1.36%
PT rev (3m)-0.31%
EPS NQ rev (1m)-0.57%
EPS NQ rev (3m)-4.64%
EPS NY rev (1m)-0.65%
EPS NY rev (3m)-3.72%
Revenue NQ rev (1m)-0.56%
Revenue NQ rev (3m)-2.85%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-3.44%
Valuation
Industry RankSector Rank
PE 29.75
Fwd PE 25.1
P/S 7.33
P/FCF 34.84
P/OCF 31.08
P/B 4.66
P/tB 15.62
EV/EBITDA 24.33
EPS(TTM)1.93
EY3.36%
EPS(NY)2.29
Fwd EY3.98%
FCF(TTM)1.65
FCFY2.87%
OCF(TTM)1.85
OCFY3.22%
SpS7.83
BVpS12.32
TBVpS3.68
PEG (NY)5.05
PEG (5Y)2.64
Graham Number23.13
Profitability
Industry RankSector Rank
ROA 2.82%
ROE 3.77%
ROCE 11.13%
ROIC 9.18%
ROICexc 9.85%
ROICexgc 25.05%
OM 21.73%
PM (TTM) 5.92%
GM 66.49%
FCFM 21.04%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.35
Debt/EBITDA 0.92
Cap/Depr 28.21%
Cap/Sales 2.54%
Interest Coverage 13.98
Cash Conversion 76.69%
Profit Quality 355.05%
Current Ratio 3.46
Quick Ratio 2.38
Altman-Z 10
F-Score4
WACC10.48%
ROIC/WACC0.88
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
EPS Next Y5.89%
EPS Next 2Y8.87%
EPS Next 3Y9.27%
EPS Next 5Y8.61%
Revenue 1Y (TTM)5.23%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%
Revenue Next Year1.85%
Revenue Next 2Y4.68%
Revenue Next 3Y5.9%
Revenue Next 5Y7.1%
EBIT growth 1Y-12.8%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year17.25%
EBIT Next 3Y11.13%
EBIT Next 5Y8.56%
FCF growth 1Y8.66%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-3.82%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%

BIO-TECHNE CORP / TECH FAQ

Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?

ChartMill assigns a fundamental rating of 6 / 10 to TECH.


What is the valuation status for TECH stock?

ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.


How profitable is BIO-TECHNE CORP (TECH) stock?

BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.


How financially healthy is BIO-TECHNE CORP?

The financial health rating of BIO-TECHNE CORP (TECH) is 7 / 10.


What is the expected EPS growth for BIO-TECHNE CORP (TECH) stock?

The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 5.89% in the next year.